Eagle Eye Solutions Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Eagle Eye Solutions Group şirketinin toplam hissedar öz sermayesi £34.1M ve toplam borcu £172.0K olup, bu da borç-öz sermaye oranını 0.5% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla £51.2M ve £17.1M dir. Eagle Eye Solutions Group 'in FAVÖK'ü £831.0K faiz karşılama oranı 7.4 dur. Şirketin £10.6M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

0.5%

Borç/özkaynak oranı

UK£172.00k

Borç

Faiz karşılama oranı	7.4x
Nakit	UK£10.58m
Eşitlik	UK£34.06m
Toplam yükümlülükler	UK£17.10m
Toplam varlıklar	UK£51.15m

Son finansal sağlık güncellemeleri

Is Eagle Eye Solutions Group (LON:EYE) Weighed On By Its Debt Load?

Oct 17

Recent updates

Investors Interested In Eagle Eye Solutions Group plc's (LON:EYE) Revenues

Apr 07

Is Eagle Eye Solutions Group (LON:EYE) Weighed On By Its Debt Load?

Oct 17

There's Been No Shortage Of Growth Recently For Eagle Eye Solutions Group's (LON:EYE) Returns On Capital

Mar 23

Shareholders Are Thrilled That The Eagle Eye Solutions Group (LON:EYE) Share Price Increased 128%

Feb 07

What Does Eagle Eye Solutions Group's (LON:EYE) CEO Pay Reveal?

Jan 03

Breakeven On The Horizon For Eagle Eye Solutions Group plc (LON:EYE)

Nov 29

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: EYE 'nin kısa vadeli varlıkları ( £21.1M ) kısa vadeli yükümlülüklerini ( £13.7M ) aşıyor.

Uzun Vadeli Yükümlülükler: EYE şirketinin kısa vadeli varlıkları ( £21.1M ) uzun vadeli yükümlülüklerini ( £3.4M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: EYE şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: EYE 'nin borç/öz sermaye oranı son 5 yılda 60.2% seviyesinden 0.5% seviyesine düştü.

Borç Kapsamı: EYE 'nin borcu işletme nakit akışı ( 5513.4% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: EYE 'in borcuna ilişkin faiz ödemeleri EBIT ( 7.4 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.

Eagle Eye Solutions Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Is Eagle Eye Solutions Group (LON:EYE) Weighed On By Its Debt Load?

Recent updates

Eagle Eye Solutions Group plc, Annual General Meeting, Nov 21, 2024

Full year 2024 earnings released: EPS: UK£0.20 (vs UK£0.043 in FY 2023)

New major risk - Revenue and earnings growth

Eagle Eye Solutions Group plc to Report Q4, 2024 Results on Sep 18, 2024

Investors Interested In Eagle Eye Solutions Group plc's (LON:EYE) Revenues

First half 2024 earnings released: UK£0.014 loss per share (vs UK£0.038 profit in 1H 2023)

Consensus EPS estimates fall by 34%

Chief Sales Officer exercised options and sold UK£353k worth of stock

Eagle Eye Solutions Group plc to Report First Half, 2024 Results on Mar 19, 2024

Eagle Eye Unveils EagleAI, an AI-Powered Data Science Solution Designed for Retail

Eagle Eye Unveils EagleAI, an AI-Powered Data Science Solution Designed for Retail

Consensus EPS estimates fall by 77%

New minor risk - Earnings quality

Founder exercised options and sold UK£461k worth of stock

Eagle Eye Solutions Group plc, Annual General Meeting, Nov 16, 2023

Is Eagle Eye Solutions Group (LON:EYE) Weighed On By Its Debt Load?

Consensus EPS estimates fall from profit to UK£0.03 loss

Full year 2023 earnings: EPS misses analyst expectations

Eagle Eye Announces Not Stand Re-Election of Malcolm Wall as Chair of the Board

Eagle Eye Solutions Group plc to Report Fiscal Year 2023 Results on Sep 19, 2023

Price target increased by 13% to UK£8.05

Eagle Eye Solutions Group plc to Report Fiscal Year 2023 Results on Sep 19, 2023

Eagle Eye Solutions Group plc Announces Appointment of Charlotte Stranner as Independent Non-Executive Director

First half 2023 earnings released: EPS: UK£0.038 (vs UK£0.023 in 1H 2022)

Chief Operating Officer exercised options and sold UK£174k worth of stock

Founder exercised options and sold UK£1.1m worth of stock

Eagle Eye Solutions Group plc to Report First Half, 2023 Results on Mar 14, 2023

Non-Executive Director recently sold UK£6.0m worth of stock

Eagle Eye Solutions Group plc (AIM:EYE) agreed to acquire 100% stake in UNTIENOTS SAS for €38.8 million.

Less than half of directors are independent

Consensus forecasts updated

Full year 2022 earnings: EPS misses analyst expectations

Founder exercised options and sold UK£1.1m worth of stock

Eagle Eye Solutions Group plc Provides Earnings Guidance for the Year Ending June 30, 2022

Consensus EPS estimates have been upgraded.

Less than half of directors are independent

There's Been No Shortage Of Growth Recently For Eagle Eye Solutions Group's (LON:EYE) Returns On Capital

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target decreased to UK£6.40

Eagle Eye Solutions Group plc to Report First Half, 2022 Results on Mar 16, 2022

Price target increased to UK£6.83

Full year 2021 earnings released: UK£0.002 loss per share (vs UK£0.018 loss in FY 2020)

Full year 2021 earnings released: UK£0.002 loss per share (vs UK£0.018 loss in FY 2020)

Founder exercised options and sold UK£648k worth of stock

First half 2021 earnings released: UK£0.004 loss per share (vs UK£0.025 loss in 1H 2020)

Price target increased to UK£5.98

Eagle Eye Confirms Its Role as Key Technology Provider for Virgin Red

New 90-day high: UK£4.80

Eagle Eye Solutions Group plc to Report First Half, 2021 Results on Mar 16, 2021

Shareholders Are Thrilled That The Eagle Eye Solutions Group (LON:EYE) Share Price Increased 128%

Analysts update estimates

What Does Eagle Eye Solutions Group's (LON:EYE) CEO Pay Reveal?

New 90-day high: UK£4.27

Chargebee and Eagle Eye Partner to Offer Subscription Services to Help Retail and Hospitality Companies Drive Recurring Revenue

Eagle Eye Solutions Group plc Secures Three-Year Contract with Leading Speciality Office and Home Products & Services Retailer for Real-Time Digital Marketing

New 90-day high: UK£4.09

Breakeven On The Horizon For Eagle Eye Solutions Group plc (LON:EYE)

New 90-day high: UK£3.46

Annual earnings released: Revenue beats expectations, earnings disappoint

Full year earnings released - UK£0.018 loss per share

New 90-day high: UK£3.24

New 90-day high: UK£2.72

Full year earnings released - UK£0.018 loss per share

New 90-day high - UK£2.45

New 90-day high - UK£2.09

Price target raised to UK£3.25

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin